Subsequently, the clinical characteristics of two new patients with SLC25A3 variants who presented neonatal cardiomyopathy were detailed; one did not show skeletal myopathy or elevated lactate levels. This evidence concerns the gene SLC25A3 and skeletal muscle disorder.